Skip to main content

Bimatoprost Topical Dosage

Medically reviewed by Last updated on Apr 7, 2021.

Applies to the following strengths: 0.03%

Usual Adult Dose for Hypotrichosis of the Eyelashes

Apply 1 drop to the upper eyelid margin of each eye once a day at night


  • Apply topically to clean, makeup-free skin using the supplied sterile applicators with 1 applicator for each eye.
  • Place 1 drop of this drug on an applicator; apply evenly along the skin of the upper eyelid at base of lashes.
  • Following administration, upper lid margin should feel lightly moist; if there is runoff, blot with a tissue or absorbent cloth.
  • Repeat for the opposite eyelid margin using a new sterile applicator.

  • Additional drops or applications will not increase eyelash growth.
  • Eyelash growth is expected to return to pretreatment levels upon drug discontinuation.

Use: Treatment of hypotrichosis of the eyelashes by increasing growth (e.g., length, thickness, and darkness)

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available



  • Hypersensitivity to the active component or any of the ingredients

Safety and efficacy have not been established in patients younger than 5 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:

  • Apply once a day at night
  • Prior to application, remove makeup and contact lenses, clean and dry face
  • Place 1 drop on applicator and apply evenly along the skin of the upper eyelid at base of lashes
  • Blot any runoff solution with a tissue or absorbent cloth
  • Do not apply to lower eyelids
  • Repeat dosing application to the opposite eyelid using a new applicator (1 drop per eye, each on a new applicator)
  • Use only the supplied single-use disposable applicators
  • Avoid allowing bottle tip or sterile applicator to contact fingers or any other unintended surface to avoid contamination
  • Discard disposable applicator after use

Storage requirements: Store at 2C to 25C

  • Onset of effect is gradual (significant at approximately 2 months). The effects of this drug are not permanent.
  • Any solution that gets into the eye will not cause harm and should not be rinsed.

  • OCULAR: Patients using concomitant prostaglandin analogs should be monitored for changes to intraocular pressure.

Patient advice:
  • Patients should be told that additional drops or applications will not increase eyelash growth.
  • Patients should be advised that this drug may cause eyelid skin darkening that may be reversible after discontinuation.
  • Patients should be warned that this drug may increase brown pigmentation of the iris, which is likely to be permanent.
  • Patients should be instructed to avoid application to skin surrounding the treatment area as unexpected hair growth may occur in areas repeatedly exposed to this drug.
  • Patients should be told to contact their healthcare provider if a new ocular condition occurs (e.g., trauma, infection, hypersensitivity reaction, surgery), or for any sudden decrease in vision.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.